Could a 7-Day antibiotic course be as effective as 14 days for COPD attacks?

NCT ID NCT07708337

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial investigates whether a 7-day course of antibiotics works as well as the standard 14-day course for adults hospitalized with a sudden worsening of COPD. The study involves over 500 participants and measures clinical success at 30 days, including symptom improvement and avoidance of additional antibiotics or readmission. The goal is to see if shorter treatment can reduce antibiotic use, side effects, and the risk of antibiotic resistance without compromising patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 7-day course of systemic antibiotics compared to the usual 14-day course
What this could lead to
If successful, a shorter antibiotic course could become standard for COPD flare-ups, reducing side effects and helping fight antibiotic resistance.
What could go wrong
This is a single trial in one country, and shorter treatment might not work as well for all patients, potentially leading to more treatment failures.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CDA Hospital Islamabad

    Islamabad, Pakistan, 44000, Pakistan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.